Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04212481
Other study ID # Uniport VATS ZYP1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 25, 2019
Est. completion date December 30, 2025

Study information

Verified date November 2022
Source The Second Hospital of Shandong University
Contact Yunpeng Zhao, Doctor
Phone +8618766188692
Email zyp_baggio@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Video-assisted thoracoscopic surgery (VATS) has been widely used for non-small cell lung cancer (NSCLC) for nearly two decades. Usually, it was applied through three ports with at least one drainage after surgery, which often lead to acute chest pain. Therefore, fewer, smaller ports, and wider intercostal space for surgery has been required. Uniport VATS became a feasible option with the development of surgical techniques and instruments, with potentially less postoperative pain and shorter hospital stays. However, there may be some complications, or with a longer time of operation, even more difficult in lymph nodes resection during learning curve. In our study, a Randomized Controlled Trial was designed to study the operation time, perioperative blood loss, conversion rate, duration of postoperative drainage, length of hospital stay, visual analogue score of postoperative pain, complications, and survival.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date December 30, 2025
Est. primary completion date December 30, 2022
Accepts healthy volunteers No
Gender All
Age group 25 Years to 80 Years
Eligibility Inclusion Criteria: patients with cT1-3N0-1M0 NSCLC; good cardiopulmonary function; prepared to undergo radical resection; Exclusion Criteria: patients with N3 or M1 NSCLC; poor cardiopulmonary function; not be prepared to undergo radical resection;

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
uniport video-assisted thoracoscopic surgery
video-assisted thoracoscopic surgery for NSCLC using single port or two ports or three ports
two ports video-assisted thoracoscopic surgery
video-assisted thoracoscopic surgery for NSCLC using two ports
three ports video-assisted thoracoscopic surgery
video-assisted thoracoscopic surgery for NSCLC using three ports

Locations

Country Name City State
China The Second Hospital of Shandong University Jinan Shandong

Sponsors (1)

Lead Sponsor Collaborator
The Second Hospital of Shandong University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary operative time operative time in minutes 1 day
Primary perioperative blood loss perioperative blood loss in milliliter 1 day
Primary conversion rate conversion rate in proportion 1 day
Primary duration of postoperative drainage duration of postoperative drainage in days within 5-7 days
Primary length of hospital stay length of hospital stay in days within 5-7 days
Primary visual analogue score of postoperative pain score within 5-7 days
Primary complications complications in rate up to 3 months
Secondary overall survival overall survival in rate up to 5 years
Secondary progression- free survival progression- free survival in rate up to 5 years